<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0011173"><a href="http://purl.obolibrary.org/obo/MONDO_0011173">MONDO:0011173</a></h3>
<p><strong>Label:</strong> thrombocythemia 2</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019111">MONDO:0019111</a> (familial thrombocytosis),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_601977">OMIM:601977</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614521">OMIM:614521</a>, <a href="http://purl.obolibrary.org/obo/OMIM_187950">OMIM:187950</a>, <a href="http://www.orpha.net/ORDO/Orphanet_71493">Orphanet:71493</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300331">OMIM:300331</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 83.71%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 80.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 80.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 75.36%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) 73.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0002795">HP:0002795</a> (Functional respiratory abnormality) and <a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0002795">HP:0002795</a> (Functional respiratory abnormality) and <a href="http://purl.obolibrary.org/obo/HP_0025408">HP:0025408</a> (Abnormal spleen morphology) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0002795">HP:0002795</a> (Functional respiratory abnormality) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0002795">HP:0002795</a> (Functional respiratory abnormality) and <a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0002795">HP:0002795</a> (Functional respiratory abnormality) and <a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0002086">HP:0002086</a> (Abnormality of the respiratory system) and <a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0002086">HP:0002086</a> (Abnormality of the respiratory system) and <a href="http://purl.obolibrary.org/obo/HP_0025408">HP:0025408</a> (Abnormal spleen morphology) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0002086">HP:0002086</a> (Abnormality of the respiratory system) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0002086">HP:0002086</a> (Abnormality of the respiratory system) and <a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001894">HP:0001894</a> (Thrombocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0002086">HP:0002086</a> (Abnormality of the respiratory system) and <a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 70.00%</li>
</ul>
</body>
</html>
